GRIP1 in Myeloid Cells in Neuroinflammation

GRIP1 is a glutamate receptor interacting protein 1 and myeloid cells consists of granulocytes and monocytes, before they have differentiated and are derived from hematopoietic stem cells. The interaction between GRIP1 and myeloid cells in inflammation is in the early stages. Here is the latest research on GRIP1 and myeloid cells in inflammation.

January 11, 2022
Open Access

G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer's disease.

Molecular Biomedicine
Smita Eknath DesaleSubashchandrabose Chinnathambi
January 8, 2022

The anti-inflammatory agent bindarit attenuates the impairment of neural development through suppression of microglial activation in a neonatal hydrocephalus mouse model.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Eri IwasawaJune Goto
December 31, 2021

INPP5D regulates the amyloid pathology in Alzheimer's disease.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Peter Bor-Chian LinAdrian L Oblak
December 31, 2021

Microglia subtype transcriptomes differ between Alzheimer Disease and control human postmortem brain samples.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
K. E. PraterSuman Jayadev
December 21, 2021
Open Access

Porphyromonas gingivalis-Induced Cognitive Impairment Is Associated With Gut Dysbiosis, Neuroinflammation, and Glymphatic Dysfunction.

Frontiers in Cellular and Infection Microbiology
Li ChiWei Teng
December 17, 2021
Open Access

The Selective Loss of Purkinje Cells Induces Specific Peripheral Immune Alterations.

Frontiers in Cellular Neuroscience
Carlos Del PilarDavid Díaz
December 17, 2021

The RNA binding protein IMP2 drives a stromal-Th17 cell circuit in autoimmune neuroinflammation.

JCI Insight
Rami BecharaSarah L Gaffen
December 3, 2021

Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function.

Acta Neuropathologica
Alanna G SpiteriNicholas J C King
November 29, 2021

Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer's Disease.

Journal of Alzheimer's Disease : JAD
Staley A Brod
November 23, 2021
Open Access

Psychological Stress as a Risk Factor for Accelerated Cellular Aging and Cognitive Decline: The Involvement of Microglia-Neuron Crosstalk.

Frontiers in Molecular Neuroscience
Micaël CarrierMarie-Ève Tremblay
November 14, 2021
Open Access

Hypothermia modulates myeloid cell polarization in neonatal hypoxic-ischemic brain injury.

Journal of Neuroinflammation
Marina SeitzJosephine Herz
November 11, 2021

Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology
Nicholas DopkinsMitzi Nagarkatti

Sign up to follow this feed and discover related papers.

Related Feeds

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

© 2022 Meta ULC. All rights reserved